Compounds > org 31710
Page last updated: 2024-09-05

org 31710 and Breast Neoplasms

org 31710 has been researched along with Breast Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Archer, TK; Deroo, BJ1
Joosten, JW; Kloosterboer, HJ; Schoonen, WG1
Cornish, AL; Lee, CS; Musgrove, EA; Sutherland, RL; Swarbrick, A1

Other Studies

3 other study(ies) available for org 31710 and Breast Neoplasms

ArticleYear
Differential activation of the IkappaBalpha and mouse mammary tumor virus promoters by progesterone and glucocorticoid receptors.
    The Journal of steroid biochemistry and molecular biology, 2002, Volume: 81, Issue:4-5

    Topics: Animals; Breast Neoplasms; Chloramphenicol O-Acetyltransferase; Chromatin; Dexamethasone; DNA-Binding Proteins; Estrenes; Furans; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Proteins; Mammary Tumor Virus, Mouse; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; Plasmids; Polymerase Chain Reaction; Progestins; Receptors, Glucocorticoid; Receptors, Progesterone; Regulatory Sequences, Nucleic Acid; RNA, Viral; Transcriptional Activation; Transfection; Tumor Cells, Cultured

2002
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
    The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:3-4

    Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured

1995
Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21.
    Molecular endocrinology (Baltimore, Md.), 1997, Volume: 11, Issue:1

    Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Drug Resistance; Estrenes; Furans; Hormone Antagonists; Humans; Mifepristone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Oncogene Proteins; Phosphorylation; Progestins; Protein Processing, Post-Translational; Recombinant Fusion Proteins; Retinoblastoma Protein; Tumor Cells, Cultured

1997